Neoplasm Treatment - Philippines
Philippines- In the Philippines, the Neoplasm Treatment market is expected to experience significant growth.
- By 2024, the projected revenue in this market is estimated to reach US$906.40m.
- This growth is anticipated to continue with an annual growth rate of 9.49% from 2024 to 2029.
- As a result, the market volume is expected to reach US$1.43bn by 2029.
- When comparing the Neoplasm Treatment market globally, United States is expected to generate the highest revenue.
- In 2024 alone, United States is projected to generate an impressive US$90.56bn.
- The Philippines has seen a significant increase in the adoption of innovative neoplasm treatment techniques, leading to improved patient outcomes.
Definition:
Neoplasm Treatment refers to the medical and surgical treatments of cancer patients who require hospitalization for their care. This includes surgeries, chemotherapy, radiation therapy, immunotherapy, and/or other treatments that require close monitoring and support from healthcare professionals. Patients will typically stay in a hospital for several days to several weeks, depending on the severity of their condition. This allows hospitals to provide the highest level of medical support and to help manage symptoms and/or side effects of the patients while they receive treatment.
Additional information:
The Neoplasm Treatments market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Inpatient treatment of cancer patients
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
